Expression of concern
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function
Paper Information
Record ID:
37933
Author(s):
Publication Date:
March 23, 2009
Retraction Date:
June 23, 2022
(3.4 years years ago)
Subjects:
Institutions:
Country:
🇫🇷 FranceArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0270655Citations (198)
198
Total Citations49
Post-Retraction(24.7%)
148
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
22
Within 1 year
18
After 2+ years
1071
Days since retraction (latest)
Targeting metastasis in paediatric bone sarcomas
E. O. J. BULL, Archana Singh, Alanna M. Harden et al. (32 authors)
Molecular Cancer
Open Access
Published: May 2025
1071 days after retraction
Phase separation of the oncogenic fusion protein EWS::FLI1 is modulated by its DNA-binding domain
Emily E. Selig, Erich J. Sohn, Aiola Stoja et al. (8 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: May 2025
1058 days after retraction
Emerging connections: Poly(ADP-ribose), FET proteins and RNA in the regulation of DNA damage condensates
Silvia Lombardi, Mara Zilocchi, Roland Nicsanu et al. (4 authors)
DNA repair
Open Access
Published: May 2025
1051 days after retraction
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma
Choon Leng So, Ye Jin Lee, Bujamin Vokshi et al. (15 authors)
Cell Reports
Open Access
Published: Apr 2025
1013 days after retraction
An evolutionarily conserved constellation of functional <i>cis</i>-elements programs the virus-responsive fate of the human (epi)genome
Marianna A. Koutsi, Marialena Pouliou, Dimitris C. Chatzopoulos et al. (8 authors)
Nucleic Acids Research
Open Access
Published: Mar 2025
2 citations
2 citations
1001 days after retraction
YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells
Rahil Noorizadeh, Barbara Sax, Tahereh Javaheri et al. (16 authors)
Cell Reports
Open Access
Published: Mar 2025
1 citation
1 citation
982 days after retraction
Subcellular localization of pro-gastrin releasing peptide in human Ewing sarcoma cell lines
Koji Muramatsu, Kouji Maruyama, Yosuke Honda et al. (12 authors)
Medical Molecular Morphology
Published: Feb 2025
971 days after retraction
Transcriptional regulation of KCNA2 coding Kv1.2 by EWS::FLI1: involvement in controlling the YAP/Hippo signalling pathway and cell proliferation
Maryne Dupuy, Anaïs Postec, Mathilde Mullard et al. (17 authors)
Cell Communication and Signaling
Open Access
Published: Dec 2024
909 days after retraction
Signaling pathways and targeted therapies in Ewing sarcoma
Jia Ke, Li Cao, Yihan Yu et al. (7 authors)
Pharmacology & Therapeutics
Open Access
Published: Nov 2024
2 citations
2 citations
891 days after retraction
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling
Maryne Dupuy, Maxime Guéguinou, Anaïs Postec et al. (21 authors)
Oncogene
Open Access
Published: Nov 2024
2 citations
2 citations
862 days after retraction
Endogenous EWSR1-FLI1 degron alleles enable control of fusion oncoprotein expression in tumor cell lines and xenografts
James F. McGinnis, Alberto Bremauntz, Florentina Vandiver et al. (12 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2024
1 citation
1 citation
859 days after retraction
Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm
Elena Vasileva, Claire Arata, Yongfeng Luo et al. (6 authors)
Unknown Journal
Open Access
Published: Oct 2024
3 citations
3 citations
859 days after retraction
Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy
Caterina Mancarella, Katia Scotlandi
Journal of Clinical Oncology
Published: Sep 2024
811 days after retraction
Prion-like domain mediated phase separation of ARID1A promotes oncogenic potential of Ewing’s sarcoma
Yong Ryoul Kim, Jaegeon Joo, Hee Jung Lee et al. (18 authors)
Nature Communications
Open Access
Published: Aug 2024
12 citations
12 citations
772 days after retraction
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants
M Frenkel, James E. Corban, Margaux L.A. Hujoel et al. (5 authors)
Nature Biotechnology
Published: Jul 2024
1 citation
1 citation
762 days after retraction
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
D. Isabel Petrescu, Jason T. Yustein, Atreyi Dasgupta
Frontiers in Oncology
Open Access
Published: Jul 2024
2 citations
2 citations
756 days after retraction
Targeting DNA Methylation Machinery in Pediatric Solid Tumors
Camilla Cristalli, Katia Scotlandi
Cells
Open Access
Published: Jul 2024
7 citations
7 citations
756 days after retraction
Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose–response relationship in <i>Drosophila</i>
Serena Mahnoor, Cristina Molnar, Diego Velázquez et al. (8 authors)
Open Biology
Open Access
Published: Jul 2024
2 citations
2 citations
739 days after retraction
Biological sample collection to advance research and treatment: a Fight Osteosarcoma Through European Research (FOSTER) and Euro Ewing Consortium (EEC) statement.
Darrell Green, Roelof van Ewijk, Elisa Tirtei et al. (56 authors)
Clinical Cancer Research
Open Access
Published: Jun 2024
5 citations
5 citations
721 days after retraction
Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles
Peter Ruzanov, Valentina Evdokimova, Manideep C. Pachva et al. (23 authors)
Journal of Clinical Investigation
Open Access
Published: Mar 2024
5 citations
5 citations
642 days after retraction
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma
Jennifer Jess, Katie M. Sorensen, Elissa A. Boguslawski et al. (16 authors)
Clinical Cancer Research
Published: Mar 2024
4 citations
4 citations
636 days after retraction
Single cell RNA-sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution
Andrew Goodspeed, Avery Bodlak, Alexis B. Duffy et al. (21 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2024
2 citations
2 citations
576 days after retraction
The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture
Joana G. Marques, Blaz Pavlovic, Quy A. Ngo et al. (10 authors)
Cancer Research
Published: Nov 2023
8 citations
8 citations
509 days after retraction
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
International Journal of Molecular Sciences
Open Access
Published: Oct 2023
12 citations
12 citations
478 days after retraction
Discovering chromatin dysregulation induced by protein-coding perturbations at scale
M Frenkel, Margaux L.A. Hujoel, Zachary S. Morris et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2023
1 citation
1 citation
455 days after retraction
Ewing sarcoma from molecular biology to the clinic
Maryne Dupuy, François Lamoureux, Mathilde Mullard et al. (11 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Sep 2023
14 citations
14 citations
445 days after retraction
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
Helong Gong, Busheng Xue, Jinlong Ru et al. (5 authors)
Cancers
Open Access
Published: Aug 2023
11 citations
11 citations
412 days after retraction
Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing
Danh D. Truong, Salah-Eddine Lamhamedi-Cherradi, R. Porter et al. (14 authors)
BMC Cancer
Open Access
Published: May 2023
14 citations
14 citations
342 days after retraction
Chimeric protein EWS-FLI1 drives cell proliferation in Ewing Sarcoma<i>via</i>overexpression of<i>KCNN1</i>
Maryne Dupuy, Maxime Guéguinou, Anaïs Postec et al. (19 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2023
309 days after retraction
(mis)-Targeting of SWI/SNF complex(es) in cancer
Divya Reddy, Saikat Bhattacharya, Jerry L. Workman
Cancer and Metastasis Reviews
Open Access
Published: Apr 2023
18 citations
18 citations
305 days after retraction
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity
Rajendran Sanalkumar, Rui Dong, Lukuo Lee et al. (20 authors)
Science Advances
Open Access
Published: Mar 2023
18 citations
18 citations
281 days after retraction
Data from EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
Michelle Kinsey, Richard Smith, Anita K. Iyer et al. (5 authors)
Unknown Journal
Open Access
Published: Mar 2023
280 days after retraction
Supplementary Table 4 from EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
Michelle Kinsey, Richard Smith, Anita K. Iyer et al. (5 authors)
Unknown Journal
Open Access
Published: Mar 2023
280 days after retraction
Supplementary Methods and Materials from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth
Didier Surdez, Magdalena Benetkiewicz, Virginie Perrin et al. (14 authors)
Unknown Journal
Open Access
Published: Mar 2023
280 days after retraction
Supplementary Methods and Materials from Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth
Didier Surdez, Magdalena Benetkiewicz, Virginie Perrin et al. (14 authors)
Unknown Journal
Open Access
Published: Mar 2023
280 days after retraction
Data from Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells <i>In vitro</i>
Dave N.T. Aryee, Stephan Niedan, Maximilian Kauer et al. (13 authors)
Unknown Journal
Open Access
Published: Mar 2023
280 days after retraction
Targeting epigenetic aberrations of sarcoma in <scp>CRISPR</scp> era
Miwa Tanaka, Takuro Nakamura
Genes Chromosomes and Cancer
Published: Mar 2023
277 days after retraction
Biochemical and biophysical characterization of the nucleic acid binding properties of the <scp>RNA</scp>/<scp>DNA</scp> binding protein <scp>EWS</scp>
Emily E. Selig, Roohi Bhura, Matthew R. White et al. (9 authors)
Biopolymers
Open Access
Published: Mar 2023
9 citations
9 citations
267 days after retraction
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
Olivia W. Lee, Calvin Rodrigues, Shu‐Hong Lin et al. (56 authors)
The American Journal of Human Genetics
Open Access
Published: Feb 2023
7 citations
7 citations
235 days after retraction
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
Diana Lu, Jana M. Ellegast, Kenneth N. Ross et al. (19 authors)
Nature Cell Biology
Open Access
Published: Jan 2023
29 citations
29 citations
210 days after retraction
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
Yuan Gao, Xue‐Yan He, Xiaoli Wu et al. (12 authors)
Nature Cell Biology
Open Access
Published: Jan 2023
24 citations
24 citations
210 days after retraction
The Role of Phase-Separated Condensates in Fusion Oncoprotein–Driven Cancers
Hazheen K. Shirnekhi, Bappaditya Chandra, Richard W. Kriwacki
Annual Review of Cancer Biology
Open Access
Published: Jan 2023
22 citations
22 citations
204 days after retraction
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications
Le Yu, Ian J. Davis, Pengda Liu
Cancers
Open Access
Published: Jan 2023
14 citations
14 citations
197 days after retraction
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
Martin F. Orth, Didier Surdez, Tobias Faehling et al. (25 authors)
Cell Reports
Open Access
Published: Dec 2022
46 citations
46 citations
161 days after retraction
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma
Shan Wang, Xiaofang Huo, Yiping Yang et al. (6 authors)
Cancer Letters
Published: Oct 2022
9 citations
9 citations
128 days after retraction
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
Tilman L. B. Hölting, Florencia Cidre‐Aranaz, Dana Matzek et al. (18 authors)
Molecular Cancer
Open Access
Published: Oct 2022
5 citations
5 citations
112 days after retraction
Regulation of Metastasis in Ewing Sarcoma
Mingli Li, Chun–Wei Chen
Cancers
Open Access
Published: Oct 2022
12 citations
12 citations
106 days after retraction
Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis
Cristina Molnar, José Reina, Anastasia Herrero et al. (11 authors)
PNAS Nexus
Open Access
Published: Sep 2022
4 citations
4 citations
70 days after retraction
Differential Impact of Random GC Tetrad Binding and Chromatin Events on Transcriptional Inhibition by Olivomycin A
Alexandra K. Isagulieva, Dmitry N. Kaluzhny, Artemy D. Beniaminov et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2022
2 citations
2 citations
47 days after retraction
Expression of Concern: The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function
Unknown Authors
PLoS ONE
Open Access
Published: Jun 2022
Same day as retraction
Quick Stats
Total Citations:
198
Years Since Retraction:
3.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025